PET with Fluorodeoxyglucose F 18/Computed Tomography as a Staging Tool in Multiple Myeloma

被引：6
作者：
Seval, Guldane Cengiz [1 ]
Ozkan, Elgin [2 ]
Beksac, Meral [1 ]
机构：
[1] Ankara Univ, Sch Med, Cebeci Res & Applicat Hosp, Dept Hematol, TR-06590 Mamak, Amkara, Turkey
[2] Ankara Univ, Sch Med, Cebeci Res & Applicat Hosp, Dept Nucl Med, TR-06590 Mamak, Amkara, Turkey
来源：
PET CLINICS | 2019年 / 14卷 / 03期
关键词：
Multiple myeloma; Staging; PET/CT; POSITRON-EMISSION-TOMOGRAPHY; BONE-MARROW ANGIOGENESIS; F-18-FDG PET/CT; FDG-PET/CT; SOLITARY PLASMACYTOMA; IMAGING TECHNIQUES; MONOCLONAL GAMMOPATHY; MANAGEMENT; GUIDELINES; DIAGNOSIS;
D O I：
10.1016/j.cpet.2019.03.009
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
In the past decade novel treatment options have dramatically prolonged the survival of patients with multiple myeloma. PET combined with computed tomography (CT) is a sensitive and reliable functional imaging tool that enables diagnosis and assessment of response to chemotherapy/radiotherapy, and combines high sensitivity in identifying both lytic lesions and extramedullary soft-tissue masses with the ability to provide reliable prognostic information in the management of patients with myeloma. This review comprises a comprehensive overview of PET with fluorodeoxyglucose F 18/CT imaging in combination with other convenient imaging procedures, and attempts at standardization with emphasis on post-therapy findings in patients with myeloma.
引用
收藏
页码：369 / +
页数：14
相关论文
共 64 条
  • [1] Adam Z, 2007, NEOPLASMA, V54, P536
  • [2] [Anonymous], BLOOD
  • [3] F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma
    Bartel, Twyla B.
    Haessler, Jeff
    Brown, Tracy L. Y.
    Shaughnessy, John D., Jr.
    van Rhee, Frits
    Anaissie, Elias
    Alpe, Terri
    Angtuaco, Edgardo
    Walker, Ronald
    Epstein, Joshua
    Crowley, John
    Barlogie, Bart
    [J]. BLOOD, 2009, 114 (10) : 2068 - 2076
  • [4] Impact of PET-CT Response on Survival Parameters Following Autologous Stem Cell Transplantation Among Patients with Multiple Myeloma: Comparison of Two Cut-Off Values
    Beksac, Meral
    Gunduz, Mehmet
    Ozen, Mehmet
    Ozturk, Sule Mine Bakanay
    Kucuk, Ozlem
    Ozkan, Elgin
    [J]. BLOOD, 2014, 124 (21)
  • [5] FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
    Boellaard, Ronald
    Delgado-Bolton, Roberto
    Oyen, Wim J. G.
    Giammarile, Francesco
    Tatsch, Klaus
    Eschner, Wolfgang
    Verzijlbergen, Fred J.
    Barrington, Sally F.
    Pike, Lucy C.
    Weber, Wolfgang A.
    Stroobants, Sigrid
    Delbeke, Dominique
    Donohoe, Kevin J.
    Holbrook, Scott
    Graham, Michael M.
    Testanera, Giorgio
    Hoekstra, Otto S.
    Zijlstra, Josee
    Visser, Eric
    Hoekstra, Corneline J.
    Pruim, Jan
    Willemsen, Antoon
    Arends, Bertjan
    Kotzerke, Joerg
    Bockisch, Andreas
    Beyer, Thomas
    Chiti, Arturo
    Krause, Bernd J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (02) : 328 - 354
  • [6] Comparison of imaging with FDG PET/CT with other imaging modalities in myeloma
    Breyer, Richard J., III
    Mulligan, Michael E.
    Smith, Stacy E.
    Line, Bruce R.
    Badros, Ashraf Z.
    [J]. SKELETAL RADIOLOGY, 2006, 35 (09) : 632 - 640
  • [7] European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when
    Caers, Jo
    Garderet, Laurent
    Kortuem, K. Martin
    O'Dwyer, Michael E.
    van de Donk, Niels W. C. J.
    Binder, Mascha
    Dold, Sandra Maria
    Gay, Francesca
    Corre, Jill
    Beguin, Yves
    Ludwig, Heinz
    Larocca, Alessandra
    Driessen, Christoph
    Dimopoulos, Meletios A.
    Boccadoro, Mario
    Gramatzki, Martin
    Zweegman, Sonja
    Einsele, Hermann
    Cavo, Michele
    Goldschmidt, Hartmut
    Sonneveld, Pieter
    Delforge, Michel
    Auner, Holger W.
    Terpos, Evangelos
    Engelhardt, Monika
    [J]. HAEMATOLOGICA, 2018, 103 (11) : 1772 - 1784
  • [8] 18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study
    Cassou-Mounat, Thibaut
    Balogova, Sona
    Nataf, Valerie
    Calzada, Marie
    Huchet, Virginie
    Kerrou, Khaldoun
    Devaux, Jean-Yves
    Mohty, Mohamad
    Talbot, Jean-Noel
    Garderet, Laurent
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (11) : 1995 - 2004
  • [9] Place of modem imaging modalities for solitary plasmacytoma: Toward improved primary staging and treatment monitoring
    Chargari, Cyrus
    Vennarini, Sabine
    Servois, Vincent
    Bonardel, Gerald
    Lahutte, Marion
    Fourquet, Alain
    Bouscary, Didier
    Kirova, Youlia M.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 (02) : 150 - 158
  • [10] 18F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders
    Dammacco, Franco
    Rubini, Giuseppe
    Ferrari, Cristina
    Vacca, Angelo
    Racanelli, Vito
    [J]. CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 15 (01) : 1 - 18
1234567